Mitochondrial dysfunction: An early event in Alzheimer pathology accumulates with age in AD transgenic mice

[1]  P. Moreira,et al.  Alzheimer's disease: a lesson from mitochondrial dysfunction. , 2007, Antioxidants & redox signaling.

[2]  Gabriele Siciliano,et al.  Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality? , 2007, Antioxidants & redox signaling.

[3]  Reham M. Abdel-Kader,et al.  Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease? , 2007, Antioxidants & redox signaling.

[4]  J. Brion,et al.  Calcium-mediated Transient Phosphorylation of Tau and Amyloid Precursor Protein Followed by Intraneuronal Amyloid-β Accumulation* , 2006, Journal of Biological Chemistry.

[5]  W. Müller,et al.  Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease , 2006, Experimental Gerontology.

[6]  X. Chen,et al.  Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease , 2005 .

[7]  A. Navarro,et al.  Vitamin E at high doses improves survival, neurological performance, and brain mitochondrial function in aging male mice. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[8]  J. Mazat,et al.  Gradual Alteration of Mitochondrial Structure and Function by β-Amyloids: Importance of Membrane Viscosity Changes, Energy Deprivation, Reactive Oxygen Species Production, and Cytochrome c Release , 2005, Journal of bioenergetics and biomembranes.

[9]  R. Ravid,et al.  Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice* , 2005, Journal of Biological Chemistry.

[10]  P. Hammerstein,et al.  Morpho-dynamic changes of mitochondria during ageing of human endothelial cells , 2005, Mechanisms of Ageing and Development.

[11]  T. Bayer,et al.  Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice , 2005, Neurobiology of Disease.

[12]  M. Nieto,et al.  Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice , 2004, Neuroscience.

[13]  C. Haass,et al.  Amyloid β-induced Changes in Nitric Oxide Production and Mitochondrial Activity Lead to Apoptosis* , 2004, Journal of Biological Chemistry.

[14]  G. Perry,et al.  Drug therapy in Alzheimer's disease [5] (multiple letters) , 2004 .

[15]  M. Bauer,et al.  Significance of Respirasomes for the Assembly/Stability of Human Respiratory Chain Complex I* , 2004, Journal of Biological Chemistry.

[16]  M. Mattson.  Pathways towards and away from Alzheimer's disease , 2004, Nature.

[17]  R. Martínez-Murillo,et al.  Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease. , 2004, Histology and histopathology.

[18]  Xi Chen,et al.  Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A␤ to Mitochondrial Toxicity in Alzheimer's Disease , 2022 .

[19]  A. Navarro,et al.  Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[20]  I. Santana,et al.  Cytochrome c oxidase is decreased in Alzheimer’s disease platelets , 2004, Neurobiology of Aging.

[21]  T. Bayer,et al.  Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice , 2003, Experimental Neurology.

[22]  Anne Eckert,et al.  Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. , 2003, Biochemical pharmacology.

[23]  A. Baracca,et al.  Rhodamine 123 as a probe of mitochondrial membrane potential: evaluation of proton flux through F(0) during ATP synthesis. , 2003, Biochimica et biophysica acta.

[24]  J. Blass.  Cerebrometabolic abnormalities in Alzheimer's disease , 2003, Neurological research.

[25]  L. Murri,et al.  Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease , 2003, Experimental Neurology.

[26]  C. Haass,et al.  Neurotoxic Mechanisms Caused by the Alzheimer's Disease-linked Swedish Amyloid Precursor Protein Mutation , 2003, Journal of Biological Chemistry.

[27]  F. LaFerla.  Calcium dyshomeostasis and intracellular signalling in alzheimer's disease , 2002, Nature Reviews Neuroscience.

[28]  C. Haass,et al.  Reduction of trophic support enhances apoptosis in PC12 cells expressing Alzheimer’s APP mutation and sensitizes cells to staurosporine-induced cell death , 2002, Journal of Molecular Neuroscience.

[29]  Gabriele Siciliano,et al.  Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer’s disease , 2002, Neurobiology of Aging.

[30]  W. Müller,et al.  Membrane-disordering effects of β-amyloid peptides , 2001 .

[31]  C. Haass,et al.  Elevated vulnerability to oxidative stress‐induced cell death and activation of caspase‐3 by the Swedish amyloid precursor protein mutation , 2001, Journal of neuroscience research.

[32]  S. Hoyer.  Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update , 2000, Experimental Gerontology.

[33]  U. F. Rasmussen,et al.  Human quadricepts muscle mitochondria: A functional characterization , 2000, Molecular and Cellular Biochemistry.

[34]  A. Nunomura,et al.  Mitochondrial abnormalities in Alzheimer disease , 2000, Neurobiology of Aging.

[35]  T. Bates,et al.  β‐Amyloid fragment 25–35 selectively decreases complex IV activity in isolated mitochondria , 1999, FEBS letters.

[36]  A. Baracca,et al.  The effect of aging and an oxidative stress on peroxide levels and the mitochondrial membrane potential in isolated rat hepatocytes , 1999, FEBS letters.

[37]  Y. Kitamura,et al.  Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease , 1998, Brain Research.

[38]  M. Esiri,et al.  Apoptosis-Related Protein Expression in the Hippocampus in Alzheimer’s Disease , 1997, Neurobiology of Aging.

[39]  D. Selkoe.  Images in neuroscience. Alzheimer's disease: from genes to pathogenesis. , 1997, The American journal of psychiatry.

[40]  P. Gluckman,et al.  Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus , 1997, Brain Research.

[41]  C. Cotman,et al.  Bax Protein Expression Is Increased in Alzheimer's Brain: Correlations with DNA Damage, Bcl‐2 Expression, and Brain Pathology , 1997, Journal of neuropathology and experimental neurology.

[42]  P. Chagnon,et al.  Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases. , 1995, Neuroreport.

[43]  J. Dykens.  Isolated Cerebral and Cerebellar Mitochondria Produce Free Radicals when Exposed to Elevated Ca2+ and Na+: Implications for Neurodegeneration , 1994, Journal of neurochemistry.

[44]  M. Mattson,et al.  A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Miquel,et al.  Age-related changes in glutathione and lipid peroxide content in mouse synaptic mitochondria: Relationship to cytochrome c oxidase decline , 1994, Neuroscience Letters.

[46]  J. Nobrega,et al.  Brain Cytochrome Oxidase in Alzheimer's Disease , 1992, Journal of neurochemistry.

[47]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[48]  H. Schägger,et al.  Blue native PAGE , 2006, Nature Protocols.

[49]  J. Blass,et al.  The role of the metabolic lesion in Alzheimer's disease. , 2002, Journal of Alzheimer's disease : JAD.

[50]  B. Van Houten,et al.  Measuring oxidative mtDNA damage and repair using quantitative PCR. , 2002, Methods in molecular biology.

[51]  S. Leutner,et al.  ROS generation, lipid peroxidation and antioxidant enzyme activities in the aging brain , 2001, Journal of Neural Transmission.

[52]  L. Packer,et al.  Mitochondrial dysfunction in the senescence accelerated mouse (SAM). , 1998, Free radical biology & medicine.

[53]  R. Kozłowski,et al.  The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. , 1993, Journal of immunological methods.